Literature DB >> 33558460

Temporomandibular joint function, periodontal health, and oral microbiome in early rheumatoid arthritis and at-risk individuals: a prospective cohort study protocol.

J M Kroese1,2,3, C M C Volgenant4,5,6, D van Schaardenburg7, B G Loos6, W Crielaard5, F Lobbezoo4.   

Abstract

OBJECTIVES/AIMS: Rheumatoid arthritis (RA) is an autoimmune disease affecting the joints, including the temporomandibular joint (TMJ). Early diagnosis and treatment can alleviate symptoms and prevent progression. Predictors for disease outcome in individuals at risk for RA are therefore valuable. While limited information is available on the prevalence of TMJ involvement in early RA, previous studies suggest that RA, periodontitis and the oral microbiome are interrelated. Predictive factors for RA development may thus be present in the oral cavity. Our two aims are: (1) to assess the prevalence of TMJ involvement in early RA, and (2) to investigate the predictive value of oral factors in RA development.
MATERIALS AND METHODS: We will include 150 individuals in this multi-center, prospective cohort study: 50 patients with early RA, 50 at-risk individuals, and 50 healthy controls. At baseline, the TMJ, periodontal health, and the oral microbiome will be examined. The general health will be followed over time, on four occasions up to 3 years. DISCUSSION: Our results will provide insight into the prevalence and clinical characterization of TMJ involvement in early RA. For at-risk individuals, oral factors can be studied as possible predictors for the development of RA.

Year:  2020        PMID: 33558460     DOI: 10.1038/s41405-020-0034-8

Source DB:  PubMed          Journal:  BDJ Open        ISSN: 2056-807X


  41 in total

Review 1.  Rheumatoid arthritis.

Authors:  David L Scott; Frederick Wolfe; Tom W J Huizinga
Journal:  Lancet       Date:  2010-09-25       Impact factor: 79.321

2.  Jaw pain: its prevalence and meaning in patients with rheumatoid arthritis, osteoarthritis, and fibromyalgia.

Authors:  Frederick Wolfe; Robert S Katz; Kaleb Michaud
Journal:  J Rheumatol       Date:  2005-12       Impact factor: 4.666

Review 3.  Management of the temporomandibular joint in rheumatoid disorders.

Authors:  A J Sidebottom; R Salha
Journal:  Br J Oral Maxillofac Surg       Date:  2012-06-01       Impact factor: 1.651

4.  Salivary gland and temporomandibular joint involvement in rheumatoid arthritis: relation to disease activity.

Authors:  K Moen; L T Bertelsen; S Hellem; R Jonsson; J G Brun
Journal:  Oral Dis       Date:  2005-01       Impact factor: 3.511

5.  Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial.

Authors:  Henrike van Dongen; Jill van Aken; Leroy R Lard; Karen Visser; H Karel Ronday; Harry M J Hulsmans; Irene Speyer; Marie-Louise Westedt; André J Peeters; Cornelia F Allaart; René E M Toes; Ferdinand C Breedveld; Tom W J Huizinga
Journal:  Arthritis Rheum       Date:  2007-05

6.  Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors.

Authors:  Markus M J Nielen; Dirkjan van Schaardenburg; Henk W Reesink; Rob J van de Stadt; Irene E van der Horst-Bruinsma; Margret H M T de Koning; Moud R Habibuw; Jan P Vandenbroucke; Ben A C Dijkmans
Journal:  Arthritis Rheum       Date:  2004-02

7.  A prediction rule for the development of arthritis in seropositive arthralgia patients.

Authors:  Lotte Arwen van de Stadt; Birgit I Witte; Wouter H Bos; Dirkjan van Schaardenburg
Journal:  Ann Rheum Dis       Date:  2012-11-23       Impact factor: 19.103

8.  Stomatognathic system involvement in rheumatoid arthritis patients.

Authors:  Andrea E Bono; Jorge Alfonso Learreta; Graciela Rodriguez; Juan Carlos Marcos
Journal:  Cranio       Date:  2014-01       Impact factor: 2.020

Review 9.  The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting.

Authors:  Vivianne Malmström; Anca I Catrina; Lars Klareskog
Journal:  Nat Rev Immunol       Date:  2016-12-05       Impact factor: 53.106

10.  Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study.

Authors:  C Rakieh; J L Nam; L Hunt; E M A Hensor; S Das; L-A Bissell; E Villeneuve; D McGonagle; R Hodgson; A Grainger; R J Wakefield; P G Conaghan; P Emery
Journal:  Ann Rheum Dis       Date:  2014-04-12       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.